SJS/TEN 2019: From science to translation

J Dermatol Sci. 2020 Apr;98(1):2-12. doi: 10.1016/j.jdermsci.2020.02.003. Epub 2020 Mar 7.

Abstract

Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are potentially life-threatening, immune-mediated adverse reactions characterized by widespread erythema, epidermal necrosis, and detachment of skin and mucosa. Efforts to grow and develop functional international collaborations and a multidisciplinary interactive network focusing on SJS/TEN as an uncommon but high burden disease will be necessary to improve efforts in prevention, early diagnosis and improved acute and long-term management. SJS/TEN 2019: From Science to Translation was a 1.5-day scientific program held April 26-27, 2019, in Vancouver, Canada. The meeting successfully engaged clinicians, researchers, and patients and conducted many productive discussions on research and patient care needs.

Keywords: Human leukocyte antigen (HLA); Pharmacogenomics; Pharmacovigilance; Severe cutaneous adverse reaction (SCAR); Stevens-Johnson syndrome (SJS); Toxic epidermal necrolysis (TEN).

MeSH terms

  • Congresses as Topic
  • Global Burden of Disease
  • Global Health
  • Health Services Needs and Demand / organization & administration*
  • Humans
  • International Cooperation
  • Patient Care Team / organization & administration*
  • Pharmacogenetics / organization & administration
  • Registries / statistics & numerical data
  • Stevens-Johnson Syndrome / epidemiology
  • Stevens-Johnson Syndrome / etiology
  • Stevens-Johnson Syndrome / therapy*
  • Translational Medical Research / organization & administration